AstraZeneca shares rally 13%, hit record high as firm gets nod for cancer drug

September 24, 2024
Uncategorized

Astrazeneca Pharma India has received CDSO’s (Central Drugs Standard Control Organisation) nod for the import of Durvalumab for its sale and distribution.

AstraZeneca shares rally 13%, hit record high as firm gets nod for cancer drug

Leave a ReplyCancel Reply

Adani Ports will raise a billion dollars more after its largest ever bond issue in India

HCG eyes 20% margin in FY26 amid outpatient shift, strong urban growth

IRB Infrastructure to transfer ₹8,450 crore highway assets to invIT arm by Q2 FY26

SEBI confirms market ban on LS Industries, promoter, 4 others

IRB Infrastructure’s arm to transfer three BOT highway assets worth ₹8,450 crore to IRB InvIT